The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization. Sekhar KR, Reddy YT, Reddy PN, Crooks PA, Venkateswaran A, McDonald WH, Geng L, Sasi S, Van Der Waal RP, Roti JL, Salleng KJ, Rachakonda G, Freeman ML (2011) Clin Cancer Res 17: 6490-9 Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems. Dostalek M, Hardy KD, Milne GL, Morrow JD, Chen C, Gonzalez FJ, Gu J, Ding X, Johnson DA, Johnson JA, Martin MV, Guengerich FP (2008) J Biol Chem 283: 17147-57 Barbiturates require the N terminus and first transmembrane domain of the delta subunit for enhancement of alpha1beta3delta GABAA receptor currents. Feng HJ, Macdonald RL (2010) J Biol Chem 285: 23614-21 Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. Sekhar KR, Benamar M, Venkateswaran A, Sasi S, Penthala NR, Crooks PA, Hann SR, Geng L, Balusu R, Abbas T, Freeman ML (2014) Int J Radiat Oncol Biol Phys 89: 1106-1114 In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Dostalek M, Brooks JD, Hardy KD, Milne GL, Moore MM, Sharma S, Morrow JD, Guengerich FP (2007) Mol Pharmacol 72: 1419-24 Drugs, alcohol and sex hormones: a molecular perspective of the receptivity of cytochrome P-450. Estabrook RW, Mason JI, Baron J, Lambeth D, Waterman M (1973) Ann N Y Acad Sci 212: 27-49 Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents. Reddy YT, Sekhar KR, Sasi N, Reddy PN, Freeman ML, Crooks PA (2010) Bioorg Med Chem Lett 20: 600-2 The induction of microsomal electron transport enzymes. Waterman MR, Estabrook RW (1983) Mol Cell Biochem 53-54: 267-78 Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience. Sanghani NS, Haase VH (2019) Adv Chronic Kidney Dis 26: 253-266 HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism. Haase VH (2017) Hemodial Int 21 Suppl 1: S110-S124
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.